Patent ID: 7968562

Claim:
A method of treating a dermal associated condition without undesired systemic absorption of the IRM, the method comprising a step of: applying to skin a topical formulation comprising an immune response modifier (IRM) compound 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine or a pharmaceutically acceptable salt thereof; a fatty acid; and a hydrophobic, aprotic component miscible with the fatty acid and comprising a hydrocarbyl group of 7 or more carbon atoms, wherein the hydrophobic, aprotic component is caprylic/capric triglyceride, wherein the formulation is applied for a period of time sufficient to obtain a desired therapeutic effect without undesired systemic absorption of the IRM compound, and the dermal associated condition is selected from the group consisting of actinic keratosis, postsurgical scars, basal cell carcinoma, atopic dermatitis, and warts.